Total Liabilities

$123.93M

Quarterly · Period ending: Sep 30, 2020 · USD

PDLI Total Liabilities

Latest reported$123.93Mperiod endingSep 30, 2020

PDLI Quarterly Total Liabilities ($5.00M → $123.93M)

Quarterly total liabilities

High-resolution chart · PNG

PDLI total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pdl Biopharma Inc Total Liabilities — Quarterly (USD)
Period ending	Total Liabilities (USD)
Sep 30, 2020	123,928,000
Jun 30, 2020	100,655,000
Mar 31, 2020	106,688,000
Dec 31, 2019	122,841,000
Sep 30, 2019	227,711,000
Jun 30, 2019	225,037,000
Mar 31, 2019	229,749,000
Dec 31, 2018	233,957,000
Sep 30, 2018	245,040,000
Jun 30, 2018	233,367,000
Mar 31, 2018	257,292,000
Dec 31, 2017	397,233,000
Sep 30, 2017	400,856,000
Jun 30, 2017	483,173,000
Mar 31, 2017	474,837,000
Dec 31, 2016	459,964,000
Sep 30, 2016	462,210,000
Jun 30, 2016	310,539,000
Mar 31, 2016	312,844,000
Dec 31, 2015	320,226,000
Sep 30, 2015	424,644,000
Jun 30, 2015	468,327,000
Mar 31, 2015	662,189,000
Dec 31, 2014	501,913,000
Sep 30, 2014	577,863,000
Jun 30, 2014	619,744,000
Mar 31, 2014	650,365,000
Dec 31, 2013	430,466,000
Sep 30, 2013	376,785,000
Jun 30, 2013	402,685,000
Mar 31, 2013	406,481,000
Dec 31, 2012	348,088,000
Sep 30, 2012	365,380,000
Jun 30, 2012	420,943,000
Mar 31, 2012	478,743,000
Dec 31, 2011	473,744,000
Sep 30, 2011	513,764,000
Jun 30, 2011	577,768,000
Mar 31, 2011	619,908,000
Dec 31, 2010	640,848,000
Sep 30, 2010	562,049,000
Jun 30, 2010	706,389,000
Mar 31, 2010	859,310,000
Dec 31, 2009	754,364,000
Sep 30, 2009	506,843,000
Jun 30, 2009	524,877,000
Mar 31, 2009	641,362,000
Dec 31, 2008	543,711,000
Sep 30, 2008	651,870,000
Jun 30, 2008	627,011,000
Mar 31, 2008	638,991,000
Dec 31, 2007	684,582,000
Sep 30, 2007	651,535,000
Jun 30, 2007	669,881,000
Mar 31, 2007	653,971,000
Dec 31, 2006	674,352,000
Sep 30, 2006	656,096,000
Jun 30, 2006	642,204,000
Mar 31, 2006	640,007,000
Dec 31, 2005	639,936,000
Sep 30, 2005	625,003,000
Jun 30, 2005	577,303,000
Mar 31, 2005	578,234,000
Dec 31, 2004	301,222,000
Sep 30, 2004	304,063,000
Jun 30, 2004	288,355,000
Mar 31, 2004	291,947,000
Dec 31, 2003	293,699,000
Sep 30, 2003	442,653,000
Jun 30, 2003	185,304,000
Mar 31, 2003	171,365,000
Dec 31, 2002	173,052,000
Sep 30, 2002	169,856,000
Jun 30, 2002	170,430,000
Mar 31, 2002	167,978,000
Dec 31, 2001	171,455,000
Sep 30, 2001	167,794,000
Jun 30, 2001	169,066,000
Mar 31, 2001	168,057,000
Dec 31, 2000	170,836,000
Sep 30, 2000	169,263,000
Jun 30, 2000	168,988,000
Mar 31, 2000	168,612,000
Dec 31, 1999	17,900,000
Sep 30, 1999	17,200,000
Jun 30, 1999	9,400,000
Mar 31, 1999	9,200,000
Dec 31, 1998	9,400,000
Sep 30, 1998	10,900,000
Jun 30, 1998	7,500,000
Mar 31, 1998	7,700,000
Dec 31, 1997	6,500,000
Sep 30, 1997	4,300,000
Jun 30, 1997	4,800,000
Mar 31, 1997	5,400,000
Dec 31, 1996	5,200,000
Sep 30, 1996	5,000,000